• D K Verma, A C Ritchie, and M L Shaw.
• Program in Occupational Health and Environmental Medicine and the Occupational and Environmental Health Laboratory, McMaster University, Hamilton, Ontario, Canada. vermadk@mcmaster.ca
• Occup Med (Lond). 2003 May 1;53(3):223-7.

BackgroundThe clinical features of chronic beryllium disease (CBD) are similar to many other chronic lung diseases. In particular, it may be difficult to distinguish it from pulmonary sarcoidosis since the two conditions may be very alike in clinical, pathological and radiological features. Aim To determine if the amount of beryllium found in the lungs could be used to differentiate CBD from sarcoidosis and controls.MethodsAnalyses for beryllium in the autopsied lung tissues of 29 cases and controls were carried out. The cases included one CBD, three confirmed sarcoidosis and 25 controls. Blocks of formalin-fixed tissues were analysed by an atomic absorption spectrophotometer equipped with a graphite furnace. A method for analysis of beryllium in air was modified to permit tissue analysis.ResultsThe CBD case had a much higher average beryllium level, but some individual results were similar to controls and patients with sarcoidosis.ConclusionThe CBD case had beryllium levels within the range of values reported in the literature. The differentiation between CBD and sarcoidosis could not be made with reasonable assurance based only on the analytic result. Occupational history is very important in making a diagnosis of CBD, along with the analysis of tissues. Tissue analysis helped confirm the diagnosis of compensatable CBD in this particular case.

18 keywords...

hide…